Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: One on each of two loci, GSTM3 and XRCC1 (codon 280)

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 9, 2005, Pages 2106-2112

  Majumder, Mousumi ^a   Sikdar, Nilabja ^a   Paul, Ranjan Rashmi ^b   Roy, Bidyut ^a  

^a INDIAN STATISTICAL INSTITUTE   (India)

^b DR R AHMED DENTAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER; CANCER RISK; CODON; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKELESS TOBACCO; SMOKING;

ADULT; AGED; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HAPLOTYPES; HUMANS; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 27744439536     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0108     Document Type: Article

References (35)

1. Nair UJ, Nair J, Mathew B, Bartsch H. Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carcinogenesis 1999;20:743-8.
2. WHO. Definition of leukoplakia and related lesions: an aid to studies to precancer. Oral Surg Oral Med Oral Pathol 1978;46:517-39.
3. Gupta PC, Mehta FS, Daftary DK, et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol 1980;8:287-333.
4. Nair UJ, Obe G, Friesen MD, Goldberg MT, Bartsch H. Role of lime in the generation of reactive oxygen species from betel quid ingredients. Environ Health Perspect 1997;98:203-5.
5. Shiu MN, Chen TH. Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer. Eur J Cancer Prev 2004;13:39-45.
6. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
7. Gupta PC, Murti PR, Bhonsle RB. Epidemiology of cancer by tobacco products and its significance of TSNA. Grit Rev Toxicol 1996;26:183-98.
8. Sen U, Shankaranarayanan R, Mandai S, Ramanakumar AV, Parkin MD, Siddiqi M. Cancer patients in Eastern India: the first report of the Kolkata cancer registry. Int J Cancer 2002;100:86-91.
9. Sikdar N, Paul RR, Roy B. Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers. Int J Cancer 2004;109:95-101.
10. Jahnke V, Strange R, Matthias C, Fryer A. Glutathione S-transferase and cytochrome P450 genotypes as a risk factors for laryngeal carcinoma. Eur Arch Otorhinolaryngol 1997;254:147-9.
11. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-44.
12. Jourenkova-Mironova N, Reinikainen M, Bouchardy C, Dayer P, Benhamou S, Hirvonen A. Larynx cancer risk in relation to glutathione S-transierase M1 and T1 genotypes and tobacco smoking. Cancer Epidemiol Biomarkers Prev 1998;7:19-23.
13. Nakajima J, Elovaara E, Anttila S, Hirvonen A, Camus AM, Hayes JD. Expression of polymorphism of glutathione S-transferase in human lungs: risk factors in smoking related lung cancer. Carcinogenesis 1995;16:707-11.
14. Oude Ophuis MB, Mulder TP, Peters WH, Manni JJ. Plasma GSTP1-1 levels in patients with head and neck squamous cell carcinoma. Cancer 1998;82:2434-48.
15. Popanda O, Schattenberg T, Phong CT, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 2004;25:2433-41.
16. 1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999;59:2557-61.
17. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-30.
18. Shen H, Sturgis EM, Dahlstrom KR, Zheng Y, Spitz MR, Wei Q. A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer 2002;99:869-72.
19. Buch SC, Notani PN, Bhisey RA. Polymorphism at GSTM1, GSTM3 and GSST1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis 2002;23:803-7.
20. Miller SA, Dykes DD, Polesky HK. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
21. Abdel-Rahman SZ, Soliman AS, Bondy ML, et al. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett 2000;159:79-86.
22. David-Beabes G, Lunn RM, London S. No association between the XPD (Lys751Gln) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:911-2.
23. Tuimala J, Szekely G, Wikman H, et al. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrations. Mutat Res 2004;554:319-33.
24. Schoonjans F. MedCalc Software, ed. 7.4 Meriakerke; 1993.
25. Majumdar P, Majumder PP. HAPLOFREQ: a computer program for maximum likelihood estimation of haplotype frequencies in a population from genotype data on unrelated individuals via the EM algorithm. Indian Statistical Institute. Tech. Rep. no. (2000) ISI/AHGU/1, Kolkata, India.
26. Tae K, Lee HS, Park BJ, et al. Association of DNA repair gene XRCC2 polymorphisms with head and neck cancer in Korean population. Int J Cancer 2004;111:805-8.
27. Sturgis EM, Castillo EJ, Li L, et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999;20:2125-9.
28. Olshan AF, Watson MA, Weissler MC, Bell DA. XRCC1 polymorphisms and head and neck cancer. Cancer Lett 2002;178:181-6.
29. Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair 2003;2:901-8.
30. Ratnasinghe D, Yao SX, Tangrea JA, et al. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:119-23.
31. Matullo G, Guarrera S, Carturan S, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 2001;92:562-7.
32. Butkiewicz D, Grzybowska E, Phillips DH, Hemminki K, Chorazy M. Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells. Environ Mol Mutagen 2000;35:99-105.
33. Matullo G, Peluso M, Polidoro S, et al. Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev 2003;12:674-7.
34. Hsieh LL, Chien HT, Chen IH, et al. The XRCC1399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 2003;12:439-43.
35. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000;97:10483-8.